【中银国际:升中国生物制药(01177.HK)目标价至7.7港元 重申“买入”评级】智通财经APP获悉,中银国际发布研报

智通财经
21 Jul
【中银国际:升中国生物制药(01177.HK)目标价至7.7港元 重申“买入”评级】智通财经APP获悉,中银国际发布研报称,中国生物制药(01177.HK)宣布以逾5亿美元净额收购礼新医药近95.09%股份,完成交易后拥有8个临床阶段候选药物的礼新将成为其间接全资子公司,重申“买入”评级,目标价由4.5港元上调至7.7港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10